Non-Hodgkin lymphoma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 20: Line 20:
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Precursor T-acute lymphoblastic leukemia / [[lymphoblastic lymphoma]] (LBL)
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Precursor T-acute lymphoblastic leukemia / [[lymphoblastic lymphoma]] (LBL)
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; text-align: center; font-weight: bold;" | Peripheral B-cell neoplasms
| style="padding: 5px 5px; background: #DCDCDC; text-align: center; font-weight: bold;" | Mature B-cell neoplasms
| style="padding: 5px 5px; background: #DCDCDC; text-align: center; font-weight: bold;" | Peripheral T-cell and NK-cell neoplasms
| style="padding: 5px 5px; background: #DCDCDC; text-align: center; font-weight: bold;" | Peripheral T-cell and NK-cell neoplasms
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | B-cell CLL / [[small lymphocytic lymphoma]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Chronic lymphocytic leukemia]] / [[Chronic lymphocytic leukemia|small lymphocytic lymphoma]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | T-cell CLL / prolymphocytic leukemia
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | T-cell CLL / prolymphocytic leukemia
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | B-cell prolymphocytic leukemia
|[[Monoclonal B-cell lymphocytosis]]
|
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[B-cell prolymphocytic leukemia]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[T-cell granular lymphocytic leukemia]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[T-cell granular lymphocytic leukemia]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Lymphoplasmacytic lymphoma / immunocytoma
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Splenic marginal zone lymphoma]] (± villous lymphocytes)
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Extranodal T-/NK-cell lymphoma, nasal type
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Hairy cell leukemia]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Enteropathy-type intestinal T-cell lymphoma]]
|-
|Splenic B-cell lymphoma/leukemia, unclassifiable
1. Splenic diffuse re pulp small B-cell lymphoma
 
2. Hairy cell leukemia-variant
|
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Lymphoplasmacytic lymphoma
Walderstorm macrogloubulinemia
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mycosis fungoides]] / [[Sézary syndrome]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mycosis fungoides]] / [[Sézary syndrome]]
|-
|[[Monoclonal gammopathy of undetermined significance]] (MGUS),
# IgM*
2. IgG/A
|
|-
|µ heavy-chain disease
ɣ heavy-chain disease
α heavy-chain disease
|
|-
|[[Multiple myeloma|Plasma cell myeloma]] (multiple myloma)
|
|-
|Solitary plasmacytoma of bone
|
|-
|Extraosseous plasmacytoma
|
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mantle cell lymphoma]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mantle cell lymphoma]]
Line 43: Line 80:
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Nodal marginal zone B-cell lymphoma]] (± monocytoid B-cells)
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Nodal marginal zone B-cell lymphoma]] (± monocytoid B-cells)
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Angioimmunoblastic T-cell lymphoma
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Angioimmunoblastic T-cell lymphoma
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Splenic marginal zone lymphoma]] (± villous lymphocytes)
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Extranodal T-/NK-cell lymphoma, nasal type
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Hairy cell leukemia]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Enteropathy-type intestinal T-cell lymphoma]]
|-
|-
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Plasmacytoma / [[plasma cell myeloma]]
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Plasmacytoma / [[plasma cell myeloma]]

Revision as of 17:33, 14 December 2018

Non-Hodgkin lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Hodgkin's Lymphoma

Differentiating Non-Hodgkin Lymphoma from Other Diseases
Differentiating Types of Non-Hodgkin's Lymphoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Hodgkin lymphoma classification On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Hodgkin lymphoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Hodgkin lymphoma classification

CDC on Non-Hodgkin lymphoma classification

Non-Hodgkin lymphoma classification in the news

Blogs on Non-Hodgkin lymphoma classification

Directions to Hospitals Treating Non-Hodgkin lymphoma

Risk calculators and risk factors for Non-Hodgkin lymphoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Non-Hodgkin lymphoma may be classified into subtypes according to updated WHO classification and rate of growth.

Classification

A. Updated WHO classification

  • Non-Hodgkin lymphoma may be classified according to updated WHO classification into 2 groups:[1]
  • B-cell neoplasms
  • T-cell and putative NK-cell neoplasms
Updated WHO classification of Non-Hodgkin lymphoma
B-cell neoplasms T-cell and putative NK-cell neoplasms
Precursor B-cell neoplasm Precursor T-cell neoplasm
Precursor B-acute lymphoblastic leukemia / lymphoblastic lymphoma (LBL) Precursor T-acute lymphoblastic leukemia / lymphoblastic lymphoma (LBL)
Mature B-cell neoplasms Peripheral T-cell and NK-cell neoplasms
Chronic lymphocytic leukemia / small lymphocytic lymphoma T-cell CLL / prolymphocytic leukemia
Monoclonal B-cell lymphocytosis
B-cell prolymphocytic leukemia T-cell granular lymphocytic leukemia
Splenic marginal zone lymphoma (± villous lymphocytes) Extranodal T-/NK-cell lymphoma, nasal type
Hairy cell leukemia Enteropathy-type intestinal T-cell lymphoma
Splenic B-cell lymphoma/leukemia, unclassifiable

1. Splenic diffuse re pulp small B-cell lymphoma

2. Hairy cell leukemia-variant

Lymphoplasmacytic lymphoma

Walderstorm macrogloubulinemia

Mycosis fungoides / Sézary syndrome
Monoclonal gammopathy of undetermined significance (MGUS),
  1. IgM*

2. IgG/A

µ heavy-chain disease

ɣ heavy-chain disease

α heavy-chain disease

Plasma cell myeloma (multiple myloma)
Solitary plasmacytoma of bone
Extraosseous plasmacytoma
Mantle cell lymphoma Peripheral T-cell lymphoma, not otherwise characterized
Follicular lymphoma Hepatosplenic gamma / delta T-cell lymphoma
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphatic tissue (MALT) type Subcutaneous panniculitis-like T-cell lymphoma
Nodal marginal zone B-cell lymphoma (± monocytoid B-cells) Angioimmunoblastic T-cell lymphoma
Plasmacytoma / plasma cell myeloma Adult T-cell lymphoma / leukemia (human T-lymphotrophic virus [HTLV] 1+)
Diffuse large B-cell lymphoma Anaplastic large cell lymphoma, primary systemic type
Burkitt lymphoma Anaplastic large cell lymphoma, primary cutaneous type
Aggressive NK-cell leukemia

B. Classification based on rate of growth

  • Non-Hodgkin lymphoma may be classified based on rate of growth into 2 groups:[2]
  • Low-grade or Indolent lymphoma
  • High-grade or Aggressive lymphoma
Non-Hodgkin lymphoma classification
Grade Description
Low-grade or Indolent lymphoma
  • Tend to grow very slowly
  • Tend to be widespread by the time they are diagnosed
  • Often involving the bone marrow and spleen
  • Often treated only when symptoms appear
  • Can shrink or seem to disappear with treatment, but they tend to come back
  • Can change into more aggressive lymphomas
  • Have a fairly good prognosis
High-grade or Aggressive lymphoma
  • Grow quickly and tend to spread to lymph nodes or other organs throughout the body
  • Cause symptoms and need treatment right away
  • Can frequently be successfully treated with intensive chemotherapy treatment
Non-Hodgkin's Lymphoma

References

  1. National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/publications/pdq
  2. "Canadian Cancer Society Grades of non-Hodgkin lymphoma".

Template:Hematology


Template:WikiDoc Sources